Gossamer Bio Inc (NASDAQ: GOSS) on Monday, soared 12.50% from the previous trading day, before settling in for the closing price of $1.36. Within the past 52 weeks, GOSS’s price has moved between $0.66 and $1.55.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 40.29% over the past five years. The company achieved an average annual earnings per share of -169.82%. With a float of $182.66 million, this company’s outstanding shares have now reached $227.22 million.
Let’s look at the performance matrix of the company that is accounted for 145 employees. In terms of profitability, gross margin is 100.0%, operating margin of -43.96%, and the pretax margin is -40.41%.
Gossamer Bio Inc (GOSS) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Gossamer Bio Inc is 19.64%, while institutional ownership is 58.38%.
Gossamer Bio Inc (GOSS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -169.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.90% during the next five years compared to 40.29% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Gossamer Bio Inc (GOSS) is currently performing well based on its current performance indicators. A quick ratio of 5.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (NASDAQ: GOSS) saw its 5-day average volume 1.66 million, a negative change from its year-to-date volume of 1.69 million. As of the previous 9 days, the stock’s Stochastic %D was 88.14%.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 97.47%, which indicates a significant increase from 97.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0857 in the past 14 days, which was lower than the 0.1042 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2214, while its 200-day Moving Average is $1.0426. Nevertheless, the first resistance level for the watch stands at $1.5850 in the near term. At $1.6400, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7400. If the price goes on to break the first support level at $1.4300, it is likely to go to the next support level at $1.3300. The third support level lies at $1.2750 if the price breaches the second support level.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
Market capitalization of the company is 347.77 million based on 227,302K outstanding shares. Right now, sales total 114,700 K and income totals -56,530 K. The company made 9,890 K in profit during its latest quarter, and -36,640 K in sales during its previous quarter.
